Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month" ALT"Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month"March 7, 2017By Alex Keown,…

Continue ReadingWhy Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month

FDA Places Clinical Hold on Scynexis’ IV Antifungal, Lifts Hold on Seattle Genetics AML Treatment

The FDA has asked Scynexis to hold new clinical studies of an intravenous formulation of its antifungal treatment, SCY-078, until the agency can review available pre-clinical and clinical data. Source:…

Continue ReadingFDA Places Clinical Hold on Scynexis’ IV Antifungal, Lifts Hold on Seattle Genetics AML Treatment

Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roivant-vivek-ramaswamy.jpg" NAME"Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina" ALT"Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina"March 6, 2017By Alex Keown...…

Continue ReadingBiotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina